Center for Biologics Evaluation and Research

The Center for Biologics Evaluation and Research (CBER) is a part of the U.S. Food and Drug Administration (FDA) that ensures the safety and effectiveness of biological products, such as vaccines, blood products, and gene therapies. CBER's role includes reviewing research data, regulating manufacturing practices, and monitoring the use of these products to protect public health. By overseeing the approval process and ongoing safety evaluations, CBER helps ensure that biologics are safe for people to use, promoting trust in these critical medical advancements.